blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4316598

EP4316598 - PHARMACEUTICAL COMPOSITION CONTAINING POORLY-SOLUBLE BASIC MEDICINE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  12.07.2024
Database last updated on 24.07.2024
FormerThe application has been published
Status updated on  05.01.2024
Most recent event   Tooltip12.07.2024The date on which the examining division becomes responsible, has been established 
12.07.2024Request for examination filedpublished on 14.08.2024 [2024/33]
12.07.2024Change - designated statespublished on 14.08.2024 [2024/33]
Applicant(s)For all designated states
CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, 5-chome Ukima
Kita-ku
Tokyo 115-8543 / JP
[2024/06]
Inventor(s)01 / KITAYAMA, Akira
Tokyo, 115-8543 / JP
02 / SASOH, Takeshi
Tokyo, 115-8543 / JP
 [2024/06]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2024/06]
Application number, filing date23212247.328.06.2019
[2024/06]
Priority number, dateJP2018012483029.06.2018         Original published format: JP 2018124830
[2024/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4316598
Date:07.02.2024
Language:EN
[2024/06]
Type: A3 Search report 
No.:EP4316598
Date:17.04.2024
Language:EN
[2024/16]
Search report(s)(Supplementary) European search report - dispatched on:EP20.03.2024
ClassificationIPC:A61K31/5377, A61K9/20, A61K47/02, A61K47/18, A61K47/20, A61K47/32, A61K47/38, A61P25/24, A61P25/28, A61P35/00, A61P35/04, A61P43/00
[2024/16]
CPC:
A61K9/2009 (EP,KR,US); A61K31/5377 (EP,IL,KR,US); A61K9/2013 (EP,KR,US);
A61K47/02 (IL); A61K47/18 (IL); A61K47/20 (IL,KR);
A61K47/32 (IL); A61K47/38 (IL); A61K9/20 (IL);
A61K9/2018 (US); A61K9/2027 (KR,US); A61K9/205 (KR);
A61K9/2054 (US); A61K9/2059 (KR); A61P25/24 (EP,IL,KR);
A61P25/28 (EP,IL,KR); A61P35/00 (EP,IL,KR); A61P35/04 (EP,IL,KR);
A61P43/00 (EP,IL) (-)
Former IPC [2024/06]A61P43/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/33]
Former [2024/06]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT SCHWER LÖSLICHER BASISCHER MEDIZIN[2024/07]
English:PHARMACEUTICAL COMPOSITION CONTAINING POORLY-SOLUBLE BASIC MEDICINE[2024/06]
French:COMPOSITION PHARMACEUTIQUE CONTENANT UN MÉDICAMENT BASIQUE PEU SOLUBLE[2024/07]
Former [2024/06]PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EIN SCHWERLÖSLICHES BASISCHES MEDIKAMENT
Former [2024/06]COMPOSITION PHARMACEUTIQUE CONTENANT UN MÉDICAMENT BASIQUE FAIBLEMENT SOLUBLE
Examination procedure11.07.2024Examination requested  [2024/33]
11.07.2024Date on which the examining division has become responsible
Parent application(s)   TooltipEP19826841.9  / EP3815688
Fees paidRenewal fee
21.12.2023Renewal fee patent year 03
21.12.2023Renewal fee patent year 04
21.12.2023Renewal fee patent year 05
24.06.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2012023597  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al);
 [A]WO2015163448  (CHUGAI PHARMACEUTICAL CO LTD [JP]);
 [A]WO2016021707  (CHUGAI PHARMACEUTICAL CO LTD [JP]);
by applicantJP2009100783
 JP4588121B
 JP4918630B
 JP5006987B
 WO2015163447
 JP5859712B
 WO2016021707
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.